FULC vs RVTY · $427.0M cap vs P/E 42, rev $1.44B
Fulcrum Therapeutics Inc (FULC) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
Fulcrum Therapeutics Inc (FULC) is a biotechnology company listed on US.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Latest reported FULC revenue for 2025-09-30 was $0. Net income was -$54.5M. FULC currently screens at market cap $427.0M.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
FULC currently screens at market cap $427.0M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the FULC and RVTY stock pages for the full models.
Not investment advice.